On-Study Deaths(within 30 days of last dose)

n (%)

Total Deaths 15 (10.1)

Infection 7 (4.7)

Disease progression 5 (3.4)

Othera 3 (2.0)

a Suicide, pulmonary emboli, cerebral hemorrhage

Integrated Safety Database (N=149)

Previous slide

Next slide

Back to first slide

View graphic version